SNSE/MRKCL (SNSE/MRKCL)

Santiago Stock Exchange: SNSE/MRKCL · CLP

CLP 141,020

+0.00 (0.0%)· Recorded snapshot

Market cap	343.6T
Revenue (ttm)	61.3T
Net income (ttm)	2.9T
EPS (ttm)	CLP 1,255
P/E (trailing)	112.4x
P/E (forward)	16.8x
Dividend	CLP 3,134 (2.22%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 61.3T
Net income (ttm): 2.9T
EPS (ttm): CLP 1,255
P/E (trailing): 112.4x
P/E (forward): 16.8x
Market cap: 343.6T

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/E16.8

P25 n/aP50 n/aP75 n/a

Trailing P/E112.4

P25 n/aP50 n/aP75 n/a

ROE7

P25 n/aP50 n/aP75 n/a

ROIC14.1

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All SNSE/MRKCL indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	CLP
Country	United States
Country code	CL
Earnings date	2026-10-29
Employees	74,000
Employees change	0
Employees growth	0%
Enterprise value	CLP 389.6T
Exchange	Santiago Stock Exchange
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-08-17
Fiscal year end	December
Founded	1891
Industry	Drug Manufacturers - General
Is primary listing	No
ISIN number	US58933Y1055
Last refreshed	2026-10-28
Market cap	CLP 343.6T
Next earnings date	2026-10-29
Price	CLP 141,020.00
Price currency	CLP
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-27
Symbol	snse/MRKCL
Website	https://www.merck.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	56.04x
Average P/E ratio (3Y)	100.29x
Average P/E ratio (5Y)	71.09x
Earnings yield	0.89%
EV/Earnings	133.28x
EV/EBIT	16.89x
EV/EBITDA	13.54x
EV/FCF	26.33x
EV/Sales	5.96x
FCF / EV yield	3.8%
FCF yield	4.31%
Forward P/E	16.83x
Graham number	20699.38429
Graham upside	-85.32%
Lynch fair value	CLP 5,998.32
Lynch upside	-95.75%
P/(FCF - SBC) ratio	24.59x
P/(OCF - SBC) ratio	19.55x
P/B ratio	8.88x
P/E ratio	112.36x
P/FCF ratio	23.22x
P/OCF ratio	18.68x
P/S ratio	5.6x
Price/EBITDA ratio	12.92x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	35.28%
EBITDA margin	43.37%
Effective tax rate	46.72%
FCF margin	22.55%
Gross margin	75.9%
Operating margin	35.28%
Pretax margin	8.94%
Profit margin	4.77%
Profit per employee	CLP 39.5M
Profitable years	35
Revenue per employee	CLP 828.8M
ROA	11.87%
ROA (5Y)	11.18%
ROCE	23.01%
ROE	6.96%
ROE (5Y)	30.37%
ROIC	14.05%
ROIC (5Y)	22.36%
SBC / revenue	1.34%
Tax / revenue	4.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-80.37%
EPS growth 10Y	-3.53%
EPS growth 3Y	1.25%
EPS growth 5Y	-10.38%
EPS growth years	2
FCF growth	9.11%
FCF growth (Q)	77.03%
FCF growth (QoQ)	52.96%
FCF growth 3Y	14.05%
FCF growth 5Y	18.23%
Gross profit growth	2.6%
Gross profit growth (Q)	0.52%
Gross profit growth 3Y	5.77%
Gross profit growth 5Y	9.69%
Net income growth	-80.66%
Net income growth 3Y	0.66%
Net income growth 5Y	-10.64%
Net income growth years	2
OCF growth	7.73%
OCF growth (Q)	63.07%
OCF growth (QoQ)	37.06%
OCF growth 10Y	5.83%
OCF growth 3Y	9.82%
OCF growth 5Y	10.91%
Operating income growth	-1.53%
Operating income growth 3Y	5.7%
Operating income growth 5Y	13.81%
Revenue growth	4.64%
Revenue growth (Q)	5.07%
Revenue growth (QoQ)	1.97%
Revenue growth 10Y	5.37%
Revenue growth 3Y	4.51%
Revenue growth 5Y	8.68%
Revenue growth quarters	4
Revenue growth years	6

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	CLP -3.6T
Depreciation and amortization	CLP 5.3T
EBIT	CLP 21.6T
EBITDA	CLP 26.6T
EPS	CLP 1,255.07
Financing cash flow	CLP 5.7T
Free cash flow	CLP 14.8T
Free cash flow minus SBC	CLP 14T
Gross profit	CLP 46.5T
Income taxes	CLP 2.6T
Investing cash flow	CLP -25.1T
Net borrowing	CLP 18.4T
Net cash flow	CLP -1.1T
Net income	CLP 2.9T
Operating cash flow minus SBC	CLP 17.6T
Operating income	CLP 21.6T
Revenue	CLP 61.3T
Stock-based compensation	CLP 821.8B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	3.6
Book value per share	CLP 15,649.43
Debt / EBITDA	1.84
Debt / equity	1.28
Debt / FCF	3.36
Goodwill	CLP 21.3T
Interest coverage	13.47
Long-term assets	CLP 83.4T
Long-term liabilities	CLP 53.6T
Net cash (debt)	CLP -43.1T
Net cash / market cap	-12.54%
Net debt / EBITDA	1.62
Net debt / equity	1.11
Net debt / FCF	2.91
Piotroski F-Score	4
Property, plant and equipment	CLP 25.4T
Shareholders' equity	CLP 38.7T
Tangible book value	CLP -4.3T
Tangible book value per share	CLP -1,726.80
Total assets	CLP 119.6T
Total cash	CLP 6.6T
Total debt	CLP 49.7T
Total liabilities	CLP 80.9T

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.54
Current assets	CLP 36.2T
Current liabilities	CLP 27.3T
Current ratio	1.32
Inventory turnover	2.51
Net working capital	CLP 4.3T
Quick ratio	0.74
Working capital	CLP 8.2T
Working capital turnover	6,140.37

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	1.92%
Dividend growth	1.57%
Dividend growth (3Y)	8.62%
Dividend growth years	4
Dividend payment date	2026-10-07
Dividend payment years	6
Dividend payout frequency	Quarterly
Dividend per share	CLP 3,133.84
Dividend yield	2.22%
Ex-dividend date	2026-09-15
Last dividend	CLP 814.68
Payout ratio	261.52%
Shareholder yield	4.14%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	CLP 118,353.73
1D price change	0%
1M price change	-0.91%
1M total return	-0.91%
1W price change	1.27%
1W total return	1.27%
1Y price change	85.02%
1Y return CAGR	90.6%
1Y total return	90.52%
20-day SMA	CLP 140,358.50
200-day SMA	CLP 114,369.61
3M price change	21.5%
3M total return	22.22%
3Y price change	50.63%
3Y return CAGR	18.25%
3Y total return	65.35%
50-day SMA	CLP 137,207.80
50-day SMA vs 200-day SMA	50over200
52-week high	CLP 144,180.00
52-week high date	2026-10-05
52-week low	CLP 76,219.00
52-week low date	2025-12-01
5Y price change	108.7%
5Y return CAGR	19.54%
5Y total return	144.05%
6M price change	33.42%
6M total return	35.18%
All-time high	CLP 144,180.00
All-time high date	2026-09-29
All-time low	CLP 56,820.00
All-time low date	2021-09-21
Average true range (ATR)	CLP 590.34
Average volume	0
Change from 52-week high	-2.19%
Change from 52-week low	85.02%
Change from all-time high	-2.19%
Change from all-time low	148.19%
Monthly RSI	80.53
Previous close	CLP 141,020.00
Price vs 150-day SMA	19.15%
Price vs 20-day SMA	0.47%
Price vs 200-day SMA	23.3%
Price vs 50-day SMA	2.78%
RSI	62.3
Sharpe ratio	2.01
Sharpe ratio (3Y)	0.61
Sharpe ratio (5Y)	0.77
Sortino ratio	7.81
Sortino ratio (3Y)	1.24
Sortino ratio (5Y)	1.72
Weekly RSI	74.79
YTD price change	57.44%
YTD total return	60.71%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2.5B
Shares change (QoQ)	-0.08%
Shares change (YoY)	-1.92%
Shares held by insiders	0.05%
Shares held by institutions	81.18%
Short ratio	2.6 days

Deeper analysis on SNSE/MRKCL

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this SNSE/MRKCL report

Is a complete SNSE/MRKCL research report available?

No complete published report is available for snse/MRKCL (SNSE/MRKCL) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

SNSE/MRKCL (SNSE/MRKCL)

Price

Financial snapshot

Fair-value bridge

Latest news · SNSE/MRKCL

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All SNSE/MRKCL indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on SNSE/MRKCL

Frequently asked questions